This Study
depressive
Four hypotheses were tested for this follow-up study. The first hypothesis was that participants allocated to the treatment condition would show greater reductions in their depressive symptoms immediately following treatment (2 months after enrollment) and at the 3-month follow-up than participants in the waitlist control condition. Because treatment response has been linked to baseline symptom severity [